Authors: BARE TM

Citation: Tm. Bare, PYRIDAZINO[4,5-B]QUINOLINEDIONES - NOVEL GLYCINE N-METHYL-D-ASPARTATEANTAGONISTS FOR THE TREATMENT OF STROKE/, Journal of heterocyclic chemistry, 35(5), 1998, pp. 1171-1186

Authors: QIU H HEDLUND LW GEWALT SL BENVENISTE H BARE TM JOHNSON GA

Citation: H. Qiu et al., PROGRESSION OF A FOCAL ISCHEMIC LESION IN RAT-BRAIN DURING TREATMENT WITH A NOVEL GLYCINE NMDA ANTAGONIST - AN IN-VIVO 3-DIMENSIONAL DIFFUSION-WEIGHTED MR MICROSCOPY STUDY/, Journal of magnetic resonance imaging, 7(4), 1997, pp. 739-744

Authors: TAKANO K TATLISUMAK T FORMATO JE CARANO RAD BERGMANN AG PULLAN LM BARE TM SOTAK CH FISHER M

Citation: K. Takano et al., GLYCINE SITE ANTAGONIST ATTENUATES INFARCT SIZE IN EXPERIMENTAL FOCALISCHEMIA - POSTMORTEM AND DIFFUSION MAPPING STUDIES, Stroke, 28(6), 1997, pp. 1255-1262

Authors: TAKANO K FORMATO JE TATLISUMAK T CARANO RAD SOTAK CH BARE TM PATEL JB FISHER M

Citation: K. Takano et al., EFFECTS OF THE GLYCINE ANTAGONIST, ZD9379, ON EXPERIMENTAL FOCAL BRAIN ISCHEMIA IN RATS, Stroke, 27(1), 1996, pp. 125-125

Authors: PULLAN LM SISSON DF BARE TM CHAPDELAINE MJ STUMPO RJ

Citation: Lm. Pullan et al., NEUROPROTECTIVE GLYCINE ANTAGONISTS SUCH AS ZD9379 DO NOT PRODUCE BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC EFFECTS CHARACTERISTIC OF OTHER CLASSES OF N-METHYL-D-ASPARTATE ANTAGONISTS, Neurology, 46(2), 1996, pp. 2090-2090